Dipen J Parekh

Summary

Affiliation: University of Texas Health Science Center
Country: USA

Publications

  1. ncbi request reprint Biomarkers for prostate cancer detection
    Dipen J Parekh
    Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78284 7802, USA
    J Urol 178:2252-9. 2007
  2. ncbi request reprint Assessment of 54 biomarkers for biopsy-detectable prostate cancer
    Dipen J Parekh
    Department of Urology, University of Texas Health Sciences Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78284 7802, USA
    Cancer Epidemiol Biomarkers Prev 16:1966-72. 2007
  3. ncbi request reprint External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population
    Dipen J Parekh
    Department of Urology, University of Texas Health Science Center, San Antonio, Texas 78229, USA
    Urology 68:1152-5. 2006
  4. pmc Yearly prostate specific antigen and digital rectal examination fluctuations in a screened population
    Donna Pauler Ankerst
    Depatment of Urology, University of Texas Health Sciences Center, San Antonio, Texas, USA
    J Urol 181:2071-5; discussion 2076. 2009
  5. ncbi request reprint Prostate cancer risk with positive family history, normal prostate examination findings, and PSA less than 4.0 ng/mL
    Edith Canby-Hagino
    Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA
    Urology 70:748-52. 2007
  6. pmc microRNA-21 governs TORC1 activation in renal cancer cell proliferation and invasion
    Nirmalya Dey
    Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America
    PLoS ONE 7:e37366. 2012
  7. pmc Nox4 mediates renal cell carcinoma cell invasion through hypoxia-induced interleukin 6- and 8- production
    John P Fitzgerald
    Department of Urology, University of Texas Health Science Center, San Antonio, Texas, United States of America
    PLoS ONE 7:e30712. 2012
  8. doi request reprint Total prostate specific antigen stability confirmed after long-term storage of serum at -80C
    Amanda Beth Reed
    Department of Urology, University of Texas Health Sciences Center at San Antonio, San Antonio, Texas
    J Urol 180:534-7; discussion 537-8. 2008
  9. pmc Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group
    Donna P Ankerst
    Department of Urology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr, San Antonio, TX 78229, USA
    World J Urol 30:181-7. 2012
  10. doi request reprint Biomarkers for prostate cancer detection
    Amanda Beth Reed
    Department of Urology, University of Texas Health Sciences Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78284 7840, USA
    Expert Rev Anticancer Ther 10:103-14. 2010

Detail Information

Publications29

  1. ncbi request reprint Biomarkers for prostate cancer detection
    Dipen J Parekh
    Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78284 7802, USA
    J Urol 178:2252-9. 2007
    ..New markers that differentiate indolent from aggressive cancers to decrease potential the over treatment of prostate cancer are needed. We reviewed current and potential biomarkers for prostate cancer detection...
  2. ncbi request reprint Assessment of 54 biomarkers for biopsy-detectable prostate cancer
    Dipen J Parekh
    Department of Urology, University of Texas Health Sciences Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78284 7802, USA
    Cancer Epidemiol Biomarkers Prev 16:1966-72. 2007
    ....
  3. ncbi request reprint External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population
    Dipen J Parekh
    Department of Urology, University of Texas Health Science Center, San Antonio, Texas 78229, USA
    Urology 68:1152-5. 2006
    ....
  4. pmc Yearly prostate specific antigen and digital rectal examination fluctuations in a screened population
    Donna Pauler Ankerst
    Depatment of Urology, University of Texas Health Sciences Center, San Antonio, Texas, USA
    J Urol 181:2071-5; discussion 2076. 2009
    ..Prostate biopsy is often recommended based on increases in prostate specific antigen and/or abnormal digital rectal examination. We investigated the stability of a single positive test during the next 3 consecutive years...
  5. ncbi request reprint Prostate cancer risk with positive family history, normal prostate examination findings, and PSA less than 4.0 ng/mL
    Edith Canby-Hagino
    Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA
    Urology 70:748-52. 2007
    ..We assessed the risk of prostate cancer in men with a positive family history (at least one first-degree or second-degree relative), normal digital rectal examination (DRE) and a serum prostate-specific antigen (PSA) level of 4.0 ng/mL...
  6. pmc microRNA-21 governs TORC1 activation in renal cancer cell proliferation and invasion
    Nirmalya Dey
    Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America
    PLoS ONE 7:e37366. 2012
    ..Our results uncover a layer of post-transcriptional regulation of PTEN by transcriptional activation of miR-21 to force the canonical oncogenic Akt/TORC1 signaling conduit to drive renal cancer cell proliferation and invasion...
  7. pmc Nox4 mediates renal cell carcinoma cell invasion through hypoxia-induced interleukin 6- and 8- production
    John P Fitzgerald
    Department of Urology, University of Texas Health Science Center, San Antonio, Texas, United States of America
    PLoS ONE 7:e30712. 2012
    ..AMP-activated protein kinase (AMPK) is a highly conserved sensor of cellular energy status and a role for AMPK in the regulation of cell inflammatory processes has recently been demonstrated...
  8. doi request reprint Total prostate specific antigen stability confirmed after long-term storage of serum at -80C
    Amanda Beth Reed
    Department of Urology, University of Texas Health Sciences Center at San Antonio, San Antonio, Texas
    J Urol 180:534-7; discussion 537-8. 2008
    ..We characterized the long-term stability of total prostate specific antigen in serum samples after storage at -80C from 2001 until 2007...
  9. pmc Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group
    Donna P Ankerst
    Department of Urology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr, San Antonio, TX 78229, USA
    World J Urol 30:181-7. 2012
    ....
  10. doi request reprint Biomarkers for prostate cancer detection
    Amanda Beth Reed
    Department of Urology, University of Texas Health Sciences Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78284 7840, USA
    Expert Rev Anticancer Ther 10:103-14. 2010
    ....
  11. ncbi request reprint Current age and race adjusted prostate specific antigen threshold values delay diagnosis of high grade prostate cancer
    Amanda Reed
    Department of Urology, University of Texas Health Sciences Center San Antonio, San Antonio, Texas 78229, USA
    J Urol 178:1929-32; discussion 1932. 2007
    ..We suggest that prostate specific antigen is not a dichotomous biomarker and age specific reference ranges delays the diagnosis of high grade prostate cancer in older and black American men...
  12. doi request reprint Alvimopan for prevention of postoperative paralytic ileus in radical cystectomy patients: a cost-effectiveness analysis
    William M Hilton
    University of Texas Health Science Center, San Antonio, TX 78229, USA
    BJU Int 111:1054-60. 2013
    ..The present study provides a reasonable estimate of the cost-effectiveness of alvimopan for the prevention of postoperative ileus in the patient after radical cystectomy...
  13. ncbi request reprint Active surveillance: pitfalls to consider
    Barbara Ercole
    Department of Urology, University of Texas Health Sciences Center at San Antonio, USA
    Arch Esp Urol 64:695-702. 2011
    ..As with any active treatment option offered to patients with PCa, those who are offered AS must be appropriately selected and counseled as to its risks and benefits...
  14. pmc Tolerance of the human kidney to isolated controlled ischemia
    Dipen J Parekh
    Department of Urology, University of Texas Health Science Center San Antonio, San Antonio, Texas, USA
    J Am Soc Nephrol 24:506-17. 2013
    ..In summary, these data suggest that human kidneys can safely tolerate 30-60 minutes of controlled clamp ischemia with only mild structural changes and no acute functional loss...
  15. pmc Reduced expression of fumarate hydratase in clear cell renal cancer mediates HIF-2α accumulation and promotes migration and invasion
    Sunil Sudarshan
    Department of Urology, University of Texas Health Sciences Center at San Antonio, Texas, United States of America
    PLoS ONE 6:e21037. 2011
    ..Finally, we demonstrate that overexpression of FH in renal cancer cells inhibits cellular migration and invasion. These data provide novel insights into the tumor suppressor functions of FH in sporadic kidney cancer...
  16. doi request reprint The utility of 5-alpha reductase inhibitors in the prevention and diagnosis of prostate cancer
    Amanda Beth Reed
    Department of Urology, University of Texas Health Sciences Center at San Antonio, San Antonio, Texas 78284 7840, USA
    Curr Opin Urol 19:238-42. 2009
    ....
  17. doi request reprint Perioperative outcomes and oncologic efficacy from a pilot prospective randomized clinical trial of open versus robotic assisted radical cystectomy
    Dipen J Parekh
    Department of Urology, University of Texas Health Sciences Center at San Antonio, San Antonio, Texas, USA
    J Urol 189:474-9. 2013
    ..However, most studies are retrospective with significant selection bias...
  18. pmc The NADPH oxidase subunit p22phox inhibits the function of the tumor suppressor protein tuberin
    Karen Block
    Department of Medicine, University of Texas Health Science Center, San Antonio, Texas 78229 3900, USA
    Am J Pathol 176:2447-55. 2010
    ..Our data provide the first evidence that p22(phox)-based Nox oxidases maintain HIF-2alpha protein expression through inactivation of tuberin and downstream activation of ribosomal protein S6 kinase 1/4E-BP1 pathway...
  19. doi request reprint Surgical management of von Hippel-Lindau disease: urologic considerations
    Amanda Beth Reed
    Department of Urology, University of Texas Health Sciences Center at San Antonio, San Antonio, TX 78284 7840, USA
    Surg Oncol Clin N Am 18:157-74, x. 2009
    ....
  20. doi request reprint Efficacy of combined intravesical immunotherapy and chemotherapy for non-muscle invasive bladder cancer
    William M Hilton
    Department of Urology, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, Mail Code 7845, San Antonio, TX 78229 3900, USA
    Expert Rev Anticancer Ther 11:949-57. 2011
    ..The authors discuss the most recent data regarding combining these agents in an alternating or sequential regimen...
  21. doi request reprint Definition, incidence, risk factors, and prevention of paralytic ileus following radical cystectomy: a systematic review
    Jorge A Ramírez
    Department of Urology, The University of Texas Health Science Center San Antonio, San Antonio, TX, USA
    Eur Urol 64:588-97. 2013
    ..Postoperative paralytic ileus (POI) has profound clinical consequences because it represents a substantial burden on both patients and health care resources...
  22. doi request reprint 12th Annual meeting of the Society of Urologic Oncology (SUO) bladder cancer sessions I and II summary report
    Sam S Chang
    Department of Urology, Vanderbilt University Medical Center, Nashville, TN, USA
    Urol Oncol 30:944-7. 2012
    ....
  23. ncbi request reprint Prospective evaluation of p53 as a prognostic marker in T1 transitional cell carcinoma of the bladder
    Guido Dalbagni
    Department of Urology, Division of Epidemiology and Biostatistics, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    BJU Int 99:281-5. 2007
    ....
  24. ncbi request reprint Urinary diversion: options, patient selection, and outcomes
    Dipen J Parekh
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Semin Oncol 34:98-109. 2007
    ....
  25. doi request reprint Methods to predict and lower the risk of prostate cancer
    Barbara Ercole
    Department of Urology, University of Texas Health Science Center, San Antonio, USA
    ScientificWorldJournal 11:742-8. 2011
    ....
  26. ncbi request reprint Prostate-specific antigen levels, prostate-specific antigen kinetics, and prostate cancer prognosis: a tocsin calling for prospective studies
    Dipen J Parekh
    J Natl Cancer Inst 99:496-7. 2007
  27. ncbi request reprint Optical spectroscopy characteristics can differentiate benign and malignant renal tissues: a potentially useful modality
    Dipen J Parekh
    Department of Urologic Surgery and Biomedical Engineering, Vanderbilt University Medical Center, Nashville, Tennessee, USA
    J Urol 174:1754-8. 2005
    ..This initial study examined the feasibility of using fluorescence and diffuse reflectance spectroscopy to differentiate between malignant and benign renal tissues...
  28. ncbi request reprint Commentary on early hormonal therapy for PSA only recurrence after radical prostatectomy--success towards survival or antidote to anxiety?
    Dipen J Parekh
    J Urol 179:S60. 2008
  29. ncbi request reprint Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer
    Travis Clark
    Department of Urologic Surgery, Vanderbilt University, Nashville, TN, USA
    J Urol 169:145-7; discussion 147-8. 2003
    ..To assess the value of an extended node dissection in detecting nodal metastasis, we performed a randomized prospective study...